DSpace Repository

Serial Audiometry’s Inclusion; A Dire Need to Manage MDR/XDR-TB Patients in Order to Reduce the Emergence of Ototoxicity

Show simple item record

dc.contributor.author Humaira Zafar
dc.date.accessioned 2024-10-10T07:54:32Z
dc.date.available 2024-10-10T07:54:32Z
dc.date.issued 2013
dc.identifier.uri http://hdl.handle.net/123456789/18127
dc.description Seniors Professor Dr. Humaira Zafar, BUCM, Department of Pathology
dc.description.abstract The global burden of tuberculosis has increased a lot due to the emergence of multidrug-resistant TB (MDR-TB) and extremely drug-resistant TB (XDR-TB) cases. The current situation necessitates the need of aggressive therapy for longer duration. The use of aminoglycosides and polypeptide antibiotics as category I&II regimen have shown significant positive outcome for the management. Besides the beneficial effects, these drugs harbors serious side effects like the permanent hearing loss and the reversible renal damage. Therefore, there is a dire need of including serial audiometries amongst protocols for the patients being managed by aminoglycosides in order to minimize the emergence of permanent hearing loss. en_US
dc.language.iso en en_US
dc.publisher Isra Medical Journal en_US
dc.subject Aminoglycosides, Tuberculosis, Ototoxicity, Serial Audiometries en_US
dc.title Serial Audiometry’s Inclusion; A Dire Need to Manage MDR/XDR-TB Patients in Order to Reduce the Emergence of Ototoxicity en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account